Literature DB >> 2682098

[Anatomical basis, technic and results of narrow transanoabdominal continence resection].

F Stelzner1.   

Abstract

Ultrashort resections of the rectum have been recommended for rectal carcinomas extending below eight cm from the dentate line in order to preserve anal continence. Resection of the main lymphatic pathways together with the adjacent lamellae is important for radical removal of all tumor cells. Valves in the rectal lymph vessels allow lymph fluids to drain only in a cranial direction. There are no lymph nodes below the dorsal adjacent lamella. Thus, a distal margin of two cm from the tumor is sufficient to minimize the risk of recurrence. We recommend a trans-ano-abdominal approach for very low rectal carcinomas. During the past years, we have operated on 156 patients with rectal carcinomas and found five-year-survival rates of 50 percent with rectum resections with colostomies, 62 percent with low anterior resections and 69% with ultra-short sphincter-preserving resections.

Entities:  

Mesh:

Year:  1989        PMID: 2682098     DOI: 10.1007/bf01261474

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN: 0023-8236


  16 in total

1.  [The current status of rectal resection with sphincter retention and rectal amputation in cancer of the rectum].

Authors:  F STELZNER
Journal:  Bruns Beitr Klin Chir       Date:  1962-03

2.  Five-year results of abdominopelvic lymph node dissection for carcinoma of the rectum.

Authors:  M W STEARNS; M R DEDDISH
Journal:  Dis Colon Rectum       Date:  1959 Mar-Apr       Impact factor: 4.585

3.  Surgical procedures for carcinoma of the left colon and rectum, with five-year end results following abdominopelvic dissection of lymph nodes.

Authors:  M R DEDDISH
Journal:  Am J Surg       Date:  1960-02       Impact factor: 2.565

4.  Pelvic Recurrence after Excision of Rectum for Carcinoma.

Authors:  B C Morson; E G Vaughan; H J Bussey
Journal:  Br Med J       Date:  1963-07-06

5.  Occult hepatic metastases in colorectal carcinoma.

Authors:  I G Finlay; C S McArdle
Journal:  Br J Surg       Date:  1986-09       Impact factor: 6.939

6.  Local recurrence following 'curative' surgery for large bowel cancer: II. The rectum and rectosigmoid.

Authors:  R K Phillips; R Hittinger; L Blesovsky; J S Fry; L P Fielding
Journal:  Br J Surg       Date:  1984-01       Impact factor: 6.939

7.  Hepatic metastasis. Hepatic resection.

Authors:  M A Adson
Journal:  Dis Colon Rectum       Date:  1979-09       Impact factor: 4.585

8.  Endoluminal ultrasound in the assessment of local invasion in rectal cancer.

Authors:  J Beynon; D M Foy; A M Roe; L N Temple; N J Mortensen
Journal:  Br J Surg       Date:  1986-06       Impact factor: 6.939

9.  Radical restorative surgery for poorly differentiated carcinoma of the mid-rectum.

Authors:  M S Elliot; I P Todd; R J Nicholls
Journal:  Br J Surg       Date:  1982-05       Impact factor: 6.939

10.  The mesorectum in rectal cancer surgery--the clue to pelvic recurrence?

Authors:  R J Heald; E M Husband; R D Ryall
Journal:  Br J Surg       Date:  1982-10       Impact factor: 6.939

View more
  5 in total

Review 1.  [Subdivision of the female pelvic connective tissue: new interpretation based on morphological and embryological studies].

Authors:  H Fritsch
Journal:  Pathologe       Date:  2005-07       Impact factor: 1.011

2.  [Development and clinical anatomy of the rectal adventitia. significance for radical operation of rectal carcinoma].

Authors:  H Fritsch; W Kühnel; F Stelzner
Journal:  Langenbecks Arch Chir       Date:  1996

3.  [Electromyography of the external anal sphincter muscle and the puborectal muscle].

Authors:  F Stelzner
Journal:  Langenbecks Arch Chir       Date:  1994

Review 4.  [Surgical therapy of rectal carcinoma].

Authors:  H-P Bruch; O Schwandner; R Keller; S Farke; T H K Schiedeck
Journal:  Chirurg       Date:  2003-10       Impact factor: 0.955

5.  Topography and subdivision of the pelvic connective tissue in human fetuses and in the adult.

Authors:  H Fritsch
Journal:  Surg Radiol Anat       Date:  1994       Impact factor: 1.246

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.